regulatory review
2 stories
-
healthFDA Reverses Moderna Flu Shot Rejection Amidst Controversy
The FDA is now reviewing Moderna's mRNA flu vaccine application after an initial rejection, following a revised submission strategy and ongoing debate over mRNA technology.
-
healthFDA Reverses Decision, Agrees to Review Moderna's New Flu Vaccine
The US FDA will now review Moderna's mRNA-based flu shot after initially rejecting the application, signaling a shift in regulatory approach.